Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

James Davies has been named as one of eight researchers selected for the 2022 Fellowship scheme.

Headshot of James Davies.

Dr James Davies, an Associate Professor of Genomics at the MRC Molecular Haematology Unit has been selected as Lister Research Prize Fellow by the Lister Institute of Preventive Medicine.

The Fellowship aims to provide support at crucial stages of researchers’ careers, awarding a prize of £250,000 in flexible funding to support their research. A competitive process, prizes are awarded base on research originality, past achievements and the potential impact of the prize.

The Davies Group (Genomics and Clinical Genome Editing) specialises in the relationship between the 3D genome and gene expression. Based at the MRC Molecular Haematology Unit, the research group studies this dynamic at high resolution in order to understand how gene sequence variation and 3D structure interact to shape disease. The group is interested in using this understanding to develop advanced cellular therapies.

“I’m very much looking forward to the opportunities that the Fellowship will bring” says Professor Davies, “The Prize will provide invaluable support for my scientific career, particularly because it will give me the freedom to work on new ideas and provide access to new technologies.”

Read the full news item on the Lister Institute of Preventive Medicine website.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Biotech spinout MiroBio acquired by Gilead Sciences for ~£332m

Co-founded by Simon Davis, MiroBio focuses on developing therapeutics for inflammatory diseases.

Professor Hugh Watkins wins £30 million research award to cure killer heart diseases

The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.

Six RDM research groups secure LEAF Sustainability Awards

The Laboratory Efficiency Assessment Framework (LEAF) aims to support research groups to embed sustainability into their work.

Ewa Gogola receives Wellcome Early Career Award

Dr Ewa Gogola from the Patel Group in the MRC Molecular Haematology Unit has been awarded funding by the Wellcome Trust for the project ‘DNA damage-induced hepatocyte polyploidisation- how it happens and what are its consequences?’